Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
| DRUGNAME | PT | EventCount |
|---|---|---|
| RITUXIMAB (MOABC2B8 ANTI CD20, CHIMERIC) | Headache | 1 |
| RITUXIMAB (MOABC2B8 ANTI CD20, CHIMERIC) | Pyrexia | 1 |
| RITUXIMAB (MOABC2B8 ANTI CD20, CHIMERIC) | White blood cell count increased | 1 |
| RITUXIMAB 1000 MG IN SODIUM CHLORIDE | Drug ineffective | 1 |
| RITUXIMAB 1000 MG IN SODIUM CHLORIDE | Hypophagia | 1 |
| RITUXIMAB 1000 MG IN SODIUM CHLORIDE | Nausea | 1 |
| RITUXIMAB 1000 MG IN SODIUM CHLORIDE | Pancreatitis | 1 |
| RITUXIMAB 1000 MG IN SODIUM CHLORIDE | Urine output decreased | 1 |
| RITUXIMAB 1000 MG IN SODIUM CHLORIDE | Vomiting | 1 |
| RITUXIMAB 1000 MG IN SODIUM CHLORIDE | Weight decreased | 1 |
| RITUXIMAB BIOGEN, GENTECH | Central nervous system lesion | 1 |
| RITUXIMAB BIOGEN, GENTECH | Progressive multifocal leukoencephalopathy | 1 |
| RITUXIMAB RECOMBINANT | Blood albumin decreased | 1 |
| RITUXIMAB RECOMBINANT | Febrile neutropenia | 1 |
| RITUXIMAB RECOMBINANT | Hyperparathyroidism primary | 1 |
| RITUXIMAB RECOMBINANT | Nausea | 1 |
| RITUXIMAB RECOMBINANT | Parathyroid tumour benign | 1 |
| RITUXIMAB? | Adverse drug reaction | 1 |
| RITUXIMAB? | Oral pain | 1 |
| RITUXIMAB? | Pyrexia | 1 |
Total Records: 1,104 Number of Pages: 56